• Main Authors: Fernanda Sampaio Cavalcante, Ricardo Pinto Schuenck, Roberta Mello Ferreira Caboclo, Dennis de Carvalho Ferreira, Simone Aranha Nouér, Kátia Regina Netto dos Santos
• Format: Article
• Language: English
• Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2013-01-01
• Series: Revista da Sociedade Brasileira de Medicina Tropical
• Subjects: MRSA; SCCmec; Trimethoprim/sulfamethoxazole; Tetracycline
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100100

<sec><title>INTRODUCTION: </title>Methicillin-resistant Staphylococcus aureus (MRSA) can be difficult to detect at the clinical practice. </sec><sec><title>METHODS:</title> We analyzed 140 MRSA isolates from inpatients to correlate the antimicrobial susceptibility with the SCCmec types. </sec><sec><title>RESULTS:</title> Type III (n = 63) isolates were more resistant to ciprofloxacin, clindamycin, cloramphenicol, erythromycin, gentamicin, and rifampin than type IV (n = 65) ones (p < 0.05). Moreover, type IV isolates were susceptible to tetracycline (100%) and trimethoprim/sulfamethoxazole (98%), while type III isolates presented resistance to them. </sec><sec><title>CONCLUSIONS:</title> In regions where these SCCmec types are prevalent, the detection of specific resistant phenotypes could help to predict them, mainly when there are no technical conditions to SCCmec typing.</sec>